Revolution Medicines Clinical Trials

Revolution Medicines is evaluating potential treatments for RAS‑mutant cancers through our clinical trials.
Explore how you may be able to participate or get involved.

Select Clinical Trials in RAS‑Mutant Cancer

We have a number of clinical trials evaluating investigational RAS(ON) inhibitors.

Discover all our active clinical trials in the complete list available here: ClinicalTrials.gov.
For questions on our clinical trials, please reach out to medinfo@revmed.com or 1-844-2-REVMED (1-844-273-8633).